Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ORIG3N Inc.

www.orig3n.com

Latest From ORIG3N Inc.

Tech Transfer Roundup: Amicus Adds Gene Therapy Technology In UPenn Partnership

Amicus announced its ambitions in gene therapy last year, recently purchased Celenex and 10 pipeline candidates, and now partners with Penn on gene therapies. Celltrion is collaborating with Emory in atherosclerosis therapies.

Deals Intellectual Property

Venture Funding Deals, January 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced November through December 2015.

BioPharmaceutical Medical Device

Interest In Korean Biotech IPOs Dips Amid Year-End Rush

Bioventures seeking IPOs in the South Korean stock market are having a tough time due to waning interest from investors. A surge in such offerings this year, coupled with the usual IPO rush seen at the end of each year, have resulted in several biotech companies withdrawing plans or raising funds short of initial targets.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ORIG3N Inc.
  • Senior Management
  • Robin Y Smith, CEO
    Kate Blanchard, COO
    Marcie Glicksman, PhD, VP, Biology
    James Lovgren, CBO
    Jamie Metzl, PhD, Chief Strategy Officer
    Michael Fang, MD, Chief Medical Officer
  • Contact Info
  • ORIG3N Inc.
    Boston, MA
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register